Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Porokeratosis Companies

ID: MRFR/Pharma/4609-HCR
100 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Porokeratosis is a skin disorder characterized by the development of small, raised bumps with a surrounding ridge-like border. These lesions are known as cornoid lamellae and are a result of abnormal keratinization of the skin. While there may not be specific companies solely dedicated to porokeratosis, there are pharmaceutical and biotechnology companies that focus on dermatology and skin-related conditions, including porokeratosis. 
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Porokeratosis Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)9.23%
2024 Market Size$ 1.21 Billion
2025 Market Size$ 1.32 Billion
2035 Market Size$ 3.2 Billion

Key Players

Amgen
Novartis
Bristol-Myers Squibb
Eli Lilly and Company
Pfizer
Sanofi
Opportunities
  • Rising Healthcare Expenditure
  • Increasing Incidence of Porokeratosis
  • Technological Advancements in Treatment

Top Industry Leaders in the Porokeratosis Market

Porokeratosis Treatment Market
ย 

Latestย Porokeratosisย Companiesย Updates:

Aurinia Pharmaceuticals acquires Dermavant Sciences: This June 2023 deal strengthens Aurinia's pipeline with Dermavant's ASN-007, a promising drug for DSPPK, a severe form of porokeratosis.

PharmAust Limited partners with the University of Queensland: This collaboration aims to develop PXT3003, a potential long-term treatment for porokeratosis, with the University's expertise in skin biology and drug development.

Alma Lasers introduces Pixel CO2 laser for porokeratosis treatment: This December 2023 launch offers a minimally invasive option for treating localized porokeratosis lesions.

BioPhotas develops a novel photodynamic therapy system for porokeratosis: This technology utilizes light and photosensitive agents to target and destroy porokeratosis lesions.Companies are exploring the potential of artificial intelligence (AI) for porokeratosis diagnosis and personalized treatment recommendations.

List ofย Porokeratosisย Key companies in the market:

  • Angiodynamics, Inc. (U.S.)
  • Allergan (Republic of Ireland)
  • Alma Lasers (Israel)
  • Beiersdorf AG (Germany)
  • Biogen (U.S.)
  • Biolase Inc. (U.S.)
  • Coherent, Inc. (U.S.)
  • Coty Inc. (U.S.)
  • Cutera (U.S.)
  • Danaher Corporation (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)